InvestorsHub Logo
Followers 8
Posts 443
Boards Moderated 0
Alias Born 03/25/2016

Re: None

Tuesday, 01/04/2022 9:04:07 AM

Tuesday, January 04, 2022 9:04:07 AM

Post# of 9756
I have been following this company for years and believe there is real value in the company's IP. Assuming, there are no hiccups with regard to submitting the NDA (for the treatment of Cutaneous T-Cell Lymphoma) later in the year, the SP should recover to previous level of $2 - $3, at the very least.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNGX News